Analysis of the inflammatory cytokine network among TNFα, IL-1β, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis

Laboratory Investigation

Volumn 76, Issue 5, 1997, Pages 629-638

  Matsukawa, Akihiro ^a   Yoshimura, Teizo ^b   Miyamoto, Kazuhiko ^a   Ohkawara, Susumu ^a   Yoshinaga, Masaru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTHRITIS; ARTICLE; LEUKOCYTE MIGRATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DRUG SYNERGISM; FEMALE; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NEUTROPENIA; NEUTROPHILS; RABBITS; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030971141     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baggiolini MP, Loetscher P, and Moser B (1995). Interleukin-8 and the chemokine family. Int J Immunopharmacol 17:103-108.
2. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, and Baggiolini M (1991). Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 173:771-774.
3. Brennan FM, Chantry D, Jackson A, Maini R, and Feldmann M (1989). Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244-247.
4. Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai M, and Hebert CA (1994). Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 152:2960-2967.
5. Cassatella MA (1995). The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21-26.
6. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, and Berton G (1992). IL-8 production by human polymorphonuclear leukocytes: The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol 148:3216-3220.
7. Cassatella MA, Meda L, Bonora S, Ceska M, and Constantin G (1993). Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207-2211.
8. DeForge LE, Kenney JS, Jones ML, Warren JS, and Remick DG (1992). Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood: Separation of LPS-and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol 148:2133-2141.
9. Dinarello CA (1992). The biology of interleukin-1. Chem Immunol 51:1-32.
10. Dinarello CA (1996). Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
11. Flick DA and Gifford GE (1984). Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167-175.
12. Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, and Yoshinaga M (1996). Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. Inflamm Res 45:479-485.
13. Gordon JR and Galli SJ (1990). Mast cells as a source of both preformed and immunologically inducible TNF-alpha/ cachectin. Nature 346:274-276.
14. Goto F, Goto K, Mori S, Ohkawara S, and Yoshinaga M (1989). Biosynthesis of interleukin-I beta at inflammatory site in rabbits: Kinetics and producing cells. Br J Exp Pathol 70:597-606.
15. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, and Dinarello CA (1991). Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338:1423-1424.
16. Harada A, Sekido N, Kuno K, Akiyama M, Kasahara T, Nakanishi I, Mukaida N, and Matsushima K (1993). Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int Immunol 5:681-690.
17. Haranaka K, Satomi N, Sakurai A, and Nariuchi H (1985). Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int J Cancer 36:395-400.
18. Henderson B and Wilson M (1995). Modulins: A new class of cytokine-inducing, pro-inflammatory bacterial virulence factor. Inflamm Res 44:187-197.
19. Humphrey JH (1955). The mechanism of arthus reactions. I. The role of polymorphonuclear leukocytes and other factors in reversed passive arthus reactions in rabbits. Br J Exp Pathol 36:268-282.
20. Ito H, Shirai T, Yamamoto S, Akira M, Kawahara S, Todd CW, and Wallace RB (1986). Molecular cloning of the gene encoding rabbit tumor necrosis factor. DNA 5:157-165.
21. Lloyd AR and Oppenheim JJ (1992). Poly's lament: The neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 13: 169-172.
22. Matsukawa A, Furukawa S, Ohkawara S, Takagi K, and Yoshinaga M (1994). Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Immunol Invest 23:129-142.
23. Matsukawa A, Mori S, Ohkawara S, Maeda T, Tanase S, Edamitsu S, Yanagi F, and Yoshinaga M (1992). Production, purification and characterization of a rabbit recombinant IL-1 receptor antagonist. Biomed Res 13:269-277.
24. Matsukawa A, Ohkawara S, Maeda T, Takagi K, and Yoshinaga M (1993). Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 93:206-211.20.
25. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, and Yoshinaga M (1995). Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 154:5418-5425.
26. Mori S, Goto K, Goto F, Murakami K, Ohkawara S, and Yoshinaga M (1994). Dynamic changes in mRNA expression of neutrophils during the course of acute inflammation in rabbits. Int Immunol 6:149-156.
27. Morrison DC and Ryan JL (1987). Endotoxins and disease mechanisms. Ann Rev Med 38:417-432.
28. Pabst MJ and Johnson RBJ (1989). Bacterial lipopolysaccharide: A mediator of inflammation. In: Henson PM and Murphy RC, editors. Handbook of inflammation 6: Mediator of the inflammatory process. Amsterdam: Elsevier Press, 361-393.
29. Porat R, Poutsiaka DD, Miller LC, Granowitz EV, and Dinarello CA (1992). Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 6:2482-2486.
30. Sheron N and Williams R (1992). IL-8 as a circulating cytokine: Induction by recombinant tumour necrosis factor-alpha. Clin Exp Immunol 89:100-103.
31. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, Westwick J, and Strieter RM (1990). Interleukin-8 gene expression by a pulmonary epithelial cell line: A model for cytokine networks in the lung. J Clin Invest. 86:1945-1953.
32. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, and Kunkel SL (1992). Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141: 397-407.
33. Strieter RM, Kunkel SL, and Bone RC (1993). Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 21:5447-463.
34. Strieter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, and Marks RM (1989). Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243:1467-1469.
35. Tracey KJ (1994). Tumor necrosis factor-alpha. In: Thompson A, editor. The cytokine handbook. London: Academic, 289-304.
36. Van ZK, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, Lowry SF, and Moldawer LL (1991). IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 146:3478-3482.
37. Van ZK, Fischer E, Hawes AS, Hebert CA, Terrell TG, Baker JB, Lowry SF, and Moldawer LL (1992). Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 148:1746-1752.
38. Verghese MW and Snyderman RS (1989). Role of chemotactic and inflammatory cytokines. In: Oppenheim JJ and Sfevach E, editors. Textbook of immunology. New York: Oxford University, 274-305.
39. Wedmore CV and Williams TJ (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289:646-650.
40. Yoshimura T, Matsushima K, Oppenheim JJ, and Leonard EJ (1987a). Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1 (IL-1). J Immunol 139:788-793.
41. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, and Leonard EJ (1987b). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237.